Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Cash Flow Statement

Financials in millions AUD. Fiscal year is July - June.

Year	2023	2022	2021	2020	2019
Net Income	-19.56	-18.21	-13.88	-8.27	2.61
Depreciation & Amortization	0.38	0.39	0.42	0.37	0.16
Share-Based Compensation	0.45	0.87	0.63	0.24	0.67
Other Operating Activities	0.72	1.05	-0.01	0.13	1.35
Operating Cash Flow	-18.01	-15.9	-12.83	-7.54	4.79
Capital Expenditures	-0	-0.01	-0.22	-0.09	-0.4
Investing Cash Flow	-0	-0.01	-0.22	-0.09	-0.4
Share Issuance / Repurchase	17.88	0	25.75	2.25	0
Other Financing Activities	-1.87	-	-3.23	-0.48	-
Financing Cash Flow	16.02	0	22.52	1.77	0
Exchange Rate Effect	0.41	0.2	0.5	-0.06	-0.55
Net Cash Flow	-1.59	-15.71	9.97	-5.86	4.39
Free Cash Flow	-18.01	-15.91	-13.05	-7.63	4.39
Free Cash Flow Margin	-24017.33%	-21797.26%	-22123.73%	-7479.41%	35.99%
Free Cash Flow Per Share	-13.00	-33.10	-51.66	-127.00	87.11

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).